Changes

|Yes

|Yes

|See note

|See note

|EZH2 inhibitors like tazemetostat have shown efficacy in other hematologic malignancies, providing a rationale for their potential use in T-PLL

|''EZH2'' inhibitors like tazemetostat have shown efficacy in other hematologic malignancies, providing a rationale for their potential use in T-PLL

|-

|-

|''BCOR''

|''BCOR''